ASML vs NVAX · P/E 57, $665.37B cap vs P/E 2.5, rev $682.2M
ASML Holding NV ADR (ASML) versus Novavax Inc (NVAX) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Novavax Inc (NVAX) is a biotechnology company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported NVAX revenue for 2024-12-31 was $682.2M. Net income was -$187.5M. Revenue was down 30.7% from 2023-12-31 to 2024-12-31. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Not investment advice. Open the ASML and NVAX stock pages for the full models.
Not investment advice.